ERBB2 and non-small cell lung carcinoma: Additionally, HER2 overexpression and/or gene amplification of diverse degree has also been described in several other solid tumors including biliary tract, colon, bladder, ovarian, endometrial, head and neck and non-small cell lung cancer (NSCLC) [10].